Department of Public Health, University of Tartu, Estonia.
Health Policy. 2013 Sep;112(1-2):110-21. doi: 10.1016/j.healthpol.2013.05.011. Epub 2013 Jun 14.
We conducted this case study in order to test how health system performance could be compared using the existing national administrative health databases containing individual data. In this comparative analysis we used national data set from three countries, Estonia, Israel and Finland to follow the medical history, treatment outcome and resource use of patients with a chronic disease (diabetes) for 8 years after medical treatment was initiated.
This study showed that several clinically important aspects of quality of care as well as health policy issues of cost-effectiveness and efficiency of health systems can be assessed by using the national administrative health data systems, in case those collecting person-level health service data. We developed a structured study protocol and detailed data specifications to generate standardized data sets, in each country, for long-term follow up of incident cohort of diabetic persons as well as shared analyzing programs to produce performance measures from the standardized data sets. This stepwise decentralized approach and use of anonymous person-level data allowed us to mitigate any legal, ownership, confidentiality and privacy concerns and to create internationally comparative data with the extent of detail that is seldom seen before. For example, our preliminary performance comparisons indicate that higher mortality among relatively young diabetes patients in Estonia may be related to considerably higher rates of cardiovascular complications and lower use of statins.
Modern administrative person-level health service databases contain sufficiently rich data in details to assess the performance of health systems in the management of chronic diseases. This paper presents and discusses the methodological challenges and the way the problems were solved or avoided to enhance the representativeness and comparability of results.
我们进行这项病例研究,旨在检验如何使用包含个人数据的现有国家行政健康数据库来比较卫生系统绩效。在这项比较分析中,我们使用了来自三个国家(爱沙尼亚、以色列和芬兰)的国家数据集,对接受慢性病(糖尿病)治疗 8 年后的患者的医疗史、治疗结果和资源使用情况进行了随访。
本研究表明,通过使用国家行政健康数据系统,可以评估若干临床重要的护理质量方面以及卫生系统的成本效益和效率等卫生政策问题,前提是这些系统能够收集个人层面的健康服务数据。我们制定了一个结构化的研究方案和详细的数据规范,以生成标准化的数据集,用于长期随访糖尿病患者的新发病例队列,以及共享分析程序,以从标准化数据集中生成绩效指标。这种逐步分散的方法和使用匿名的个人层面数据,使我们能够减轻任何法律、所有权、保密性和隐私方面的担忧,并以前所未有的详细程度创建国际可比性数据。例如,我们的初步绩效比较表明,爱沙尼亚相对年轻的糖尿病患者死亡率较高,可能与心血管并发症发生率较高和他汀类药物使用率较低有关。
现代行政个人层面的健康服务数据库包含足够详细的丰富数据,可以评估卫生系统在慢性病管理方面的绩效。本文介绍并讨论了方法学挑战以及解决或避免这些问题的方法,以增强结果的代表性和可比性。